microdose glp-1 microdosing is popular, but there's little evidence it works Microdose GLP-1 (Tirzepatide) – BloomMD

That translates to an average loss of 71.2 pounds

This is because the weekly injection requires a higher dose, which may lead to more pronounced side effects compared to the daily injection

You can establish a relationship with a local physician, get regular prescriptions, and purchase from the same pharmacy consistently

The FDA warns about the opposite of microdosing, when patients exceed the dosage levels of compounded semaglutide or tirzepatide products beyond what is in the FDA-approved drug label

We estimate that these products had more than $20 billion in gross sales prior to the price reductions, so they had contributed disproportionately to the gross-to-net bubble

Nat Med 2022;28:20832091